NA

SINTETICA SA🇺🇸 United States

FDA Page

Effective Date: Jul 12, 2022
Approval ID: da0a1e50-ab34-4e5d-946e-6e0c6a7574ad
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

Lidocaine Hydrochloride Injection USP 4% [200 mg/5 mL (40 mg/mL)] Single-dose ampules ONLY FOR TOPICAL USE AND RETROBULBAR INJECTION.Rx only

Quick Stats

Total Products1

Labelers2

Label Sections12

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.